For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...
ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit in clear-cell renal-cell carcinoma, with one ...
Zacks Small Cap Research on MSN2d
RVPH: RECOVER Biomarker KOL EventRVPH RECOVER Vocal Biomarker Data On September 4, 2024, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) held a key ...
Medical Xpress on MSN6d
A new biomarker makes it easier to distinguish between Alzheimer's and primary tauopathywho is also a member of SyNergy. "The establishment of a biological definition and corresponding biomarker workflows will ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
Researchers at LMU University Hospital have discovered a novel biomarker, enhancing the differentiation between Alzheimer's ...
Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B ...
For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...
AstraZeneca has used artificial intelligence to devise a unique biomarker for its Daiichi Sankyo-partnered datopotamab ...
In short, these results revealed that both CRLF2 OE and CRLF2-d are correlated with poor prognosis in ALL patients.
Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients ...
Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback